News >

Multiomic Screening Modality Shows Promise in Early-Stage CRC

Caroline Seymour
Published: Monday, Feb 17, 2020

Girish Putcha, MD, PhD, chief medical officer and clinical laboratory director at Freenome

Girish Putcha, MD, PhD

A multiomic blood-based screening assay showed higher sensitivity and specificity versus singular tumor-based assays in detecting early-stage colorectal cancer (CRC), according to preliminary findings from the AI EMERGE trial (NCT03688906) presented at the 2020 Gastrointestinal Cancers Symposium.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication